Oral Session

[O-26] Parkinsonism and Related disorders (Imaging 2)

Fri. May 25, 2018 9:45 AM - 11:15 AM Room 2 (Sapporo Geibunkan / Zuisetsu （3F）)

Chair: Kazushi Takahashi(Department of Neurology, Saitama Medical University)

+Add all to schedule

[O-26-1] Utility of the combination of ioflupane SPECT and MIBG myocardial scintigraphy in diagnosing PD

^○Hiroaki Murata¹, Mai Tsuchiya¹, Takako Umeda², Kishin Koh¹, Takanori Hata¹, Takamura Nagasaka¹, Kazumasa Shindo¹, Hiroshi Onishi², Yoshihisa Takiyama¹ (1.Department of Neurology,University of Yamanashi, 2.Department of Radiology,University of Yamanashi)

[O-26-2] Olfactory dysfunction is related to the reduced accumulation of DAT-SPECT in Parkinson's disease

^○Atsuo Nakahara, Tadashi Umehara, Hisayoshi Oka (Department of Neurology, Daisan Hospital, The Jikei University School of Medicine)

[O-26-3] Differentiating parkinsonian syndromes using clinical brain SPECT

^○Shigetoshi Takaya^1,2,3, Nobukatsu Sawamoto^2,4, Tomohisa Okada^3,5, Gosuke Okubo⁵, Sei Nishida^3,6, Kaori Togashi⁵, Hidenao Fukuyama⁷, Ryosuke Takahashi² (1.Senri Rehabilitation Hospital, 2.Department of Neurology, Kyoto University Graduate School of Medicine, 3.Human Brain Research Center, Kyoto University Graduate School of Medicine, 4.Human Health Science, Kyoto University Graduate School of Medicine, 5.Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 6.Department of Neurosurgery, Kyoto University Graduate School of Medicine, 7.Center for the Promotion of Interdisciplinary Education and Research, Kyoto University)

[O-26-4] Amyloid imaging in Parkinson's disease patients with MCI involving olfactory dysfunction

^○Toshikazu Mino¹, Satoru Kosaka^1,2, Haruna Saito¹, Minori Kanda¹, Itsuki Hasegawa¹, Jun Takeuchi¹, Akitoshi Takeda¹, Joji Kawabe³, Yasuyoshi Watanabe⁴, Yoshiaki Itoh¹ (1.Department of Neurology, Osaka City University Graduate School of Medicine, 2.Department of Neurology, Tsukazaki Hospital, 3.Department of Nuclear Medicine, Osaka City University Graduate School of Medicine, 4.RIKEN Center for Life Science Technologies)

[O-26-5] Study of the levdopa plasma concentration in Levodopa Carbidopa intestianl gel treatment

^○Hayato Yabe¹, Haruki Ohtsubo¹, Rina Ando², Masahiro Nagai², Masahiro Nomoto² (1.Department of Neurology, Saiseikai Matsuyama Hospital, 2.Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine)

[O-26-6] Neuromelanin-related contrast in the substantia nigra decreased in generalized dystonia

^○Jun Ikezawa^1,4, Fusako Yokochi¹, Ryoichi Okiyama¹, Satoko Kumada², Maya Tojima¹, Tsutomu Kamiyama¹, Yasuhiro Nakata³, Eiji Isozaki¹ (1.Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2.Department of Neuropediatrics, Tokyo Metropolitan Neurological Hospital, 3.Department of Neuroradiology, Tokyo Metropolitan Neurological Hospital, 4.Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine)